RebrAIn

medical devices

About

RebrAIn is a medical technology company dedicated to improving neurosurgical outcomes for patients with Parkinson’s disease and Essential Tremor. Founded by experts in neurosurgery and applied mathematics, the company emerged as a spin-off from the University Hospital of Bordeaux and Inria. RebrAIn offers AI-driven software-as-a-medical-device solutions, including OptimMRI and OptimDBS, which facilitate precise brain targeting for deep brain stimulation and lesioning procedures. Their technology integrates supervised AI algorithms with a health data exchange platform, enhancing the pre-surgical planning process for neurosurgeons. The company has achieved significant regulatory milestones, including CE marking and FDA 510(k) clearance, ensuring the safety and efficacy of its products. With over 55 clinical sites adopting their solutions and more than 500 surgeries performed, RebrAIn is making a notable impact in the treatment of movement disorders across Europe and the United States.

Technologies

Outlook Microsoft Office 365 YouTube Apache reCAPTCHA Mobile Friendly Gravity Forms Bootstrap Framework Google Font API WordPress.org AI

Keywords

clinical outcomes mri targeting medical device regulation clinical trial support medical software ai-driven neurosurgery brain targeting data exchange platform clinical validation medical equipment and supplies manufacturing b2b ai medical software surgical planning neurotechnology supervised ai algorithms healthcare technology neurosurgical planning deep brain stimulation (dbs) clinical data integration patient safety ai for brain landmarks brain anatomy recognition standardized procedures targeting optimization healthcare equipment & supplies movement disorders mri-guided targeting cloud processing parkinson's disease treatment regulatory approval

Location

Avenue du Haut-Leveque, Pessac, Nouvelle-Aquitaine, France, 33600

Related Companies

Companies in the same industry